Photo / APAn influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against Covid-19 to most Americans. The FDA experts were scheduled to vote on one basic question: Does the evidence show that a Pfizer booster would be safe and effective for people 16 and older? "That would be a great way for us to monitor if we really needed booster shots," said Dr James Hildreth, president of Meharry Medical College. FDA vaccine reviewer Dr Philip Krause raised a host of questions about the reliability of one of the key studies Pfizer said showed that immunity is waning. The Biden plan has also raised major ethical concerns about impoverished parts of the world still clamouring for vaccine.

Source: New Zealand Herald September 17, 2021 20:04 UTC